VBL is among only 9% of companies across industries selected by the EIC Accelerator Funds to be used for clinical…
JI XING to Develop and CommercializeNovel Cardiac Myosin Activator in Patients with Heart Failure Cytokinetics to Receive $70 Million in…
-- Clinical development of the MYC repressor APTO-253 will be discontinued -- -- Company will focus on advancing kinome inhibitor…
CAMBRIDGE, Mass., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ: NTLA), a leading genome editing company focused on…
Company to Also Host Fireside Chat at the 24th Annual ICR Conference on January 10, 2022NEW YORK and LEAMINGTON, Ontario,…
Product is now available exclusively through Anovo specialty pharmacyProduct is stable at room temperature while Carbaglu® requires refrigerationEton Cares patient…
VANCOUVER, British Columbia, Dec. 20, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader…
NEW YORK, Dec. 20, 2021 (GLOBE NEWSWIRE) -- GBS (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing…
Employees who get COVID-19 will lose an estimated $33.3 billion in wagesSan Francisco, Dec. 20, 2021 (GLOBE NEWSWIRE) -- SAN…
- Business combination with Dynamics Special Purpose Corp. (Nasdaq: DYNS) is expected to provide more than $296 million in gross…